Voyager Therapeutics VYGR
NASDAQ VYGR
$2.45 -0.22 (-8.24%)
At close: Oct 2, 2026 · 4:00 PM EDT

Voyager Therapeutics (VYGR) Return on Sales [ROS] (2015 - 2026)

Updated

Voyager Therapeutics (VYGR) recorded Return on Sales [ROS] of -824.75% in Q2 2026, down 120.42 percentage points from -704.33% a year earlier but up 339.48 percentage points from the prior quarter.

Analysis

Voyager Therapeutics (VYGR) Return on Sales [ROS] (2015 - 2026) Analysis & Trends

On a TTM basis, Voyager Therapeutics' Return on Sales [ROS] came in at -339.32% as of Jun 30, 2026, down 49.70 percentage points year-over-year; for FY2025, it came in at -326.56%, down 222.45 percentage points from FY2024.

  • Annual Return on Sales [ROS] has a five-year change of -342.56 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Sales [ROS] came in at -104.11% in FY2024 (-152.91 pp), 48.80% in FY2023 (+173.08 pp), -124.27% in FY2022 (+72.49 pp) and -196.76% in FY2021 (-212.76 pp).
  • Quarterly Return on Sales [ROS] has ranged from -3244.68% in Q1 2022 to 81.66% in Q1 2023 over the past five years.
  • On a year-over-year basis, Return on Sales [ROS] rose in two of the last eight quarters, with an average year-over-year change of -212.41 percentage points.
  • Peak year-over-year performance for Return on Sales [ROS] in the last five years was a gain of 3326.34 percentage points in Q1 2023, against a drop of 2851.06 percentage points in Q1 2022 at the low end.
  • Per Business Quant, the preceding three quarters came in at -1164.23% (Q1 2026), -195.17% (Q4 2025) and -228.31% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Voyager Therapeutics 150.12 Mn -513.07 Mn - -824.75%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -824.75%
Mar 31, 2026 -1,164.23%
Dec 31, 2025 -195.17%
Sep 30, 2025 -228.31%
Jun 30, 2025 -704.33%
Mar 31, 2025 -533.74%
Dec 31, 2024 -610.05%
Sep 30, 2024 -55.95%
Jun 30, 2024 -50.76%
Mar 31, 2024 -82.92%
Dec 31, 2023 60.03%
Sep 30, 2023 -639.51%
Jun 30, 2023 -518.90%
Mar 31, 2023 81.66%
Dec 31, 2022 -124.28%
Sep 30, 2022 35.15%
Jun 30, 2022 -2,720.08%
Mar 31, 2022 -3,244.68%
Dec 31, 2021 20.31%
Sep 30, 2021 -1,696.76%
API Access

Voyager Therapeutics Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=VYGR&period=max&api_key=YOUR_API_KEY